Authors
Ruixin Li, Jie Liu, Xiaohui Kong, Jinhu Liu, Jia Gao, Weiwei Mu, Na Zhang, Yongjun Liu
Published in
ACS applied materials & interfaces. Nov 16, 2026. Epub Nov 16, 2026.
Abstract
Hematologic malignancies (HMs) pose a serious threat to human health and are associated with a high metastatic rate and poor prognosis. The strong tumor heterogeneity, marked therapeutic resistance, poor targeting of conventional therapies, and toxic side effects make them a major challenge in the clinical treatment of HMs. As the principal site of hematopoiesis and immune cell production, the bone marrow (BM) is a critical site in the treatment of HMs. However, low blood perfusion and the complexity of the microenvironment severely hinder drug accumulation within the BM, which is also the core bottleneck in the treatment of HMs. Owing to their unique physicochemical properties, nano-delivery systems enable efficient BM-targeted delivery, providing effective strategies to overcome this therapeutic bottleneck. This review discusses the structure of the BM and the mechanisms of delivery barriers, systematically analyzes the design advances of BM-targeted nano-delivery systems, highlights different delivery strategies, and addresses key issues in the clinical translation of nano-delivery systems, including biosafety, manufacturing, and regulation of in vivo delivery efficiency. It also outlines future directions, establishing a BM-targeted delivery framework to advance the treatment of HMs and providing a theoretical reference for the development and clinical application of BM-targeted nano-delivery systems, thereby facilitating breakthroughs in precision therapy for HMs.
PMID:
43038158
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0